ALISON BOYCE: Open Payments
NPI 1356034490 · ELKINS, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 15 payments from 8 companies in 2025. Trend: 2023 $346 · 2024 $520 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Celgene Corporation | 3 | $54 |
| Genentech USA, Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| PFIZER INC. | 2 | $41 |
| Aveo Pharmaceuticals, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Venclexta, PLUVICTO, IBRANCE, REBLOZYL, OPDIVO, LYNPARZA, EPKINLY, Tecentriq.
Industry payments across WV — which companies pay providers there.
